Page last updated: 2024-08-17

quinoxalines and Neoplasms, Nerve Sheath

quinoxalines has been researched along with Neoplasms, Nerve Sheath in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belousov, R; Brewer, KJ; Ghadimi, MP; Hoffman, A; Lazar, AJ; Lev, D; Liu, J; Lopez, G; Lusby, K; Pollock, RE; Torres, KE; Young, ED	1

Other Studies

1 other study(ies) available for quinoxalines and Neoplasms, Nerve Sheath

Article	Year
Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors. Molecular cancer therapeutics, 2012, Volume: 11, Issue:8 Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Mice; Nerve Sheath Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays	2012

Article

Year

Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors.

Molecular cancer therapeutics, 2012, Volume: 11, Issue:8

Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Mice; Nerve Sheath Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2012